This brand name is authorized in Australia, New Zealand
The drug HYLO-FRESH contains one active pharmaceutical ingredient (API):
|
1
Hyaluronate sodium
UNII YSE9PPT4TH - HYALURONATE SODIUM
|
|
|
This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:
| ATC code | Group title | Classification |
|---|---|---|
| S01XA20 | Artificial tears and other indifferent preparations | S Sensory organs → S01 Ophthalmologicals → S01X Other ophthalmologicals → S01XA Other ophthalmologicals |
This drug has been assigned below unique identifiers within the countries it is being marketed:
| Country | Identification scheme | Identifier(s) |
|---|---|---|
| Country: AU | Pharmaceutical Benefits Scheme | Identifier(s): 2181T, 2184Y |
| Country: NZ | Medicines and Medical Devices Safety Authority | Identifier(s): 15105 |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
